Cargando…

Prognostic Value of Cancer Stem Cell Markers CD44 and ALDH1/2 in Gastric Cancer Cases

PURPOSE: To determine expression levels of CD44 and ALDH1/2, known cancer stem cell (CSC) markers, in stomach adenocarcinomas and assess relationships with clinicopathologic parameters and prognosis. METHODS: Eighty patients diagnosed with gastric cancer between the years 2011-2015 were included in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Senel, Fatma, Unal, Tuba Dilay Kökenek, Karaman, Hatice, Inanç, Mevlüde, Aytekin, Aynur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720661/ https://www.ncbi.nlm.nih.gov/pubmed/28952294 http://dx.doi.org/10.22034/APJCP.2017.18.9.2527

Ejemplares similares

Spontaneous Acroangiodermatitis
por: Coban, Ipek, et al.
Publicado: (2015)

A Rare Cause of Nasal Obstruction: Metastatic Renal Cell Carcinoma
por: Kokenek-Unal, Tuba Dilay, et al.
Publicado: (2016)

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
por: Lin, Li, et al.
Publicado: (2013)

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2017)

Spindle Cell Carcinoma of the Tongue: A Rare Tumor in an Unusual Location
por: Oktay, Murat, et al.
Publicado: (2011)

Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2018)

Cancer stem cell markers ALDH1 and CD44+/CD24– phenotype and their prognosis impact in invasive ductal carcinoma
por: Rabinovich, Iris, et al.
Publicado: (2018)

Expression of Androgen Receptor and Cancer Stem Cell Markers (CD44(+)/CD24(−) and ALDH1(+)): Prognostic Implications in Invasive Breast Cancer()()
por: Riaz, Nazia, et al.
Publicado: (2018)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010)

Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer
por: Kong, Yanan, et al.
Publicado: (2018)

The diagnostic importance of matrix metalloproteinase-7 and nestin in gastrointestinal stromal tumors
por: Peker, Kemal, et al.
Publicado: (2014)

Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases
por: Horimoto, Yoshiya, et al.
Publicado: (2016)

Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC
por: Jakob, Mark, et al.
Publicado: (2020)

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma
por: Nosrati, Anahita, et al.
Publicado: (2014)

The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients
por: Izycka, Natalia, et al.
Publicado: (2023)

ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas
por: Adams, April, et al.
Publicado: (2015)

The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer
por: Huang, Hsin-Hui, et al.
Publicado: (2018)

Knockdown of ALDH1A3 reduces breast cancer stem cell marker CD44 via the miR-7-TGFBR2-Smad3-CD44 regulatory axis
por: Pan, Meng, et al.
Publicado: (2021)

STAT3 as a potential therapeutic target in ALDH(+) and CD44(+)/CD24(+) stem cell-like pancreatic cancer cells
por: Lin, Li, et al.
Publicado: (2016)

CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer
por: Go, Se-Il, et al.
Publicado: (2016)

Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells
por: Liu, Jing, et al.
Publicado: (2013)

Discrimination of Cancer Stem Cell Markers ALDH1A1, BCL11B, BMI-1, and CD44 in Different Tissues of HNSCC Patients
por: Sharaf, Kariem, et al.
Publicado: (2021)

The prognostic roles of ALDH1 isoenzymes in gastric cancer
por: Li, Kai, et al.
Publicado: (2016)

CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence
por: Hirata, K, et al.
Publicado: (2013)

Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer
por: WANG, CHUNXIA, et al.
Publicado: (2012)

The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer
por: Jang, Byung Ik, et al.
Publicado: (2011)

Immunoexperssion of cancer stem cell marker (CD44) in ameloblastoma
por: Vanje, Manjushri Madhukar, et al.
Publicado: (2019)

Goblet cell carcinoid of the appendix and mixed adenoneuroendocrine carcinoma: Report of three cases
por: Karaman, Hatice, et al.
Publicado: (2017)

CD44v3 is a marker of invasive cancer stem cells driving metastasis in gastric carcinoma
por: Giraud, Julie, et al.
Publicado: (2022)

Protein Markers Associated with an ALDH Sub-Population in Colorectal Cancer
por: Yang, Rui, et al.
Publicado: (2016)

Circulating tumor cells expressing cancer stem cell marker CD44 as a diagnostic biomarker in patients with gastric cancer
por: Watanabe, Toru, et al.
Publicado: (2017)

CD44/CD24 Expression in recurrent gastric cancer: a retrospective analysis
por: Yong, Ching-Shya, et al.
Publicado: (2012)

Reliability of CD44, CD24, and ALDH1A1 immunohistochemical staining: Pathologist assessment compared to quantitative image analysis
por: Yaghjyan, Lusine, et al.
Publicado: (2022)

Expression of CD44 Variant Exons 8‐10 in Gastric Cancer
por: Yamaguchi, Akio, et al.
Publicado: (1995)

Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma
por: ZHOU, FEI, et al.
Publicado: (2014)

Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
por: Jaggupilli, Appalaraju, et al.
Publicado: (2012)

Turkish validity and reliability of the lifestyle questionnaire related to cancer
por: Öner, Neslihan, et al.
Publicado: (2023)

CD44v6 High Membranous Expression Is a Predictive Marker of Therapy Response in Gastric Cancer Patients
por: Almeida, Gabriela M, et al.
Publicado: (2021)

Role of CD44 as a marker of cancer stem cells in head and neck cancer
por: Trapasso, Serena, et al.
Publicado: (2012)

Sarcoidosis with Multiorgan Involvement and Cutaneous Manifestations after Colonic Adenocarcinoma Resection
por: Dundar, Ayca, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hdso3nm5tisrbmnvdqm14agqos